Target intelligence / Profile preview

H type 1 antigen (H1)

Target
H1
Molecular classification
Carbohydrate, Glycan, Blood group antigen
01

Overview

H type 1 glycan is a trisaccharide structure (Fucα1-2Galβ1-3GlcNAc) that serves as a critical cell surface antigen and a precursor for the ABO blood group system (Marionneau et al., 2001, Glycobiology). Unlike H type 2, which is primarily found on erythrocytes, H type 1 is predominantly expressed on epithelial cells and in bodily secretions, regulated by the FUT2 (secretor) gene (Lindesmith et al., 2003, Nature Medicine). It plays a significant role in host-pathogen interactions, acting as a primary attachment receptor for various enteric pathogens, including noroviruses and Helicobacter pylori (Tan & Jiang, 2005, Trends in Microbiology). Individuals who lack this glycan (non-secretors) often exhibit resistance to certain viral infections but may have increased susceptibility to others, such as Crohn's disease (McGovern et al., 2010, Nature Genetics). Therapeutic strategies targeting H type 1 involve the use of glycan mimetics or decoy molecules, such as 2'-fucosyllactose, to block pathogen adhesion and prevent infection (Weichert et al., 2016, Journal of Virology).

Other names
H type 1 glycanFucα1-2Galβ1-3GlcNAcBlood group H type 1Secretor antigenH-1 antigen
02

Mechanism of action

Competitive inhibition of pathogen binding to host cell surface glycans by acting as a decoy receptor or blocking the binding site.

03

Biological functions

Cell adhesionPathogen recognitionCell-cell signalingHost-microbiome interaction
04

Disease associations

InfectionNorovirus infectionHelicobacter pylori infectionCholeraPeptic ulcer disease
05

Safety considerations

Potential for altering gut microbiota compositionInterference with normal cell-cell adhesion processesPotential impact on mucosal immunity
06

Interacting drugs

2'-Fucosyllactose

2 more in the full profile.

07

Biomarkers

Secretor status (FUT2 genotype)Salivary H type 1 levels

Beyond the preview

Go deeper on H type 1 antigen (H1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H type 1 antigen (H1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call